Aflatoxin exposure during the first 1000 days of life in rural South Asia assessed by aflatoxin B1-lysine albumin biomarkers

Food and Chemical Toxicology

Volumn 74, Issue , 2014, Pages 184-189

  Groopman, John D ^a,b   Egner, Patricia A ^a   Schulze, Kerry J ^b   Wu, Lee S F ^b   Merrill, Rebecca ^b   Mehra, Sucheta ^b   Shamim, Abu A ^b   Ali, Hasmot ^b   Shaikh, Saijuddin ^b   Gernand, Alison ^b   Khatry, Subarna K ^b   LeClerq, Steven C ^b   West, Keith P ^b   Christian, Parul ^b  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Aflatoxin; Aflatoxin B1 lysine albumin biomarkers; Child health; Maternal exposure

Indexed keywords

AFLATOXIN B1; ALBUMIN; BIOLOGICAL MARKER; C REACTIVE PROTEIN; LYSINE; OROSOMUCOID; AFLATOXIN; CARCINOGEN; SERUM ALBUMIN;

ADULT; ARTICLE; BANGLADESH; BLOOD SAMPLING; CHILD; ENVIRONMENTAL EXPOSURE; FEMALE; FETUS; FIRST TRIMESTER PREGNANCY; HUMAN; ISOTOPE DILUTION ASSAY; LONG TERM EXPOSURE; MASS SPECTROMETRY; NEPAL; NEWBORN; PRENATAL EXPOSURE; PRENATAL PERIOD; PRESCHOOL CHILD; QUANTITATIVE ANALYSIS; RURAL AREA; SEASONAL VARIATION; THIRD TRIMESTER PREGNANCY; UMBILICAL CORD BLOOD; XENOBIOTIC METABOLISM; YOUNG ADULT; ADOLESCENT; ANALYSIS; BLOOD; COHORT ANALYSIS; INFANT; PREGNANCY;

ADOLESCENT; ADULT; AFLATOXIN B1; AFLATOXINS; BANGLADESH; BIOMARKERS; CARCINOGENS; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; ENVIRONMENTAL EXPOSURE; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; LYSINE; NEPAL; PREGNANCY; SERUM ALBUMIN; YOUNG ADULT;

EID: 84908315304     PISSN: 02786915     EISSN: 18736351     Source Type: Journal    
DOI: 10.1016/j.fct.2014.09.016     Document Type: Article

References (39)

1. Begum F., Samajpati N. Mycotoxin production on rice, pulses and oilseeds. Naturwissenschaften 2000, 87:275-277.
2. Bhutta Z.A., Das J.K., Rizvi A., Gaffey M.F., Walker N., Horton S., et al. Evidence-based interventions for improvement of maternal and child nutrition: what can be done and at what cost?. Lancet 2013, 382:452-477.
3. Black R.E., Allen L.H., Bhutta Z.A., Caulfield L.E., de Onis M., Ezzati M., et al. Maternal and child undernutrition: global and regional exposures and health consequences. Lancet 2008, 371:243-260.
4. Black R.E., Victora C.G., Walker S.P., Bhutta Z.A., Christian P., de Onis M., et al. Maternal and child undernutrition and overweight in low-income and middle-income countries. Lancet 2013, 382:427-451.
5. CAST, 2003. Mycotoxins: risk in plants, animals and human systems. Council for Agricultural Science and Technology, p. 217.
6. Chen J.G., Egner P.A., Ng D., Jacobson L.P., Munoz A., Zhu Y.-R., et al. Reduced aflatoxin exposure presages decline in liver cancer mortality in an endemic region of China. Cancer Prev. Res 2013, 6:1038-1045.
7. Christian P., Schulze K., Stoltzfus R.J., West K.P. Hyporetinolemia, illness symptoms, and acute phase protein response in pregnant women with and without night blindness. Am. J. Clin. Nutr 1998, 67:1237-1243.
8. Christian P., Khatry S.K., Katz J., Pradhan E.K., LeClerq S.C., Shrestha S.R., et al. Effects of alternative maternal micronutrient supplements on low birth weight in rural Nepal: double blind randomised community trial. BMJ 2003, 326:571.
9. Christian P., West K.P., Khatry S.K., Leclerq S.C., Pradhan E.K., Katz J., et al. Effects of maternal micronutrient supplementation on fetal loss and infant mortality: a cluster-randomized trial in Nepal. Am. J. Clin. Nutr 2003, 78:1194-1202.
10. Cole R.N., Ruczinski I., Schulze K., Christian P., Herbrich S., Wu L., et al. The plasma proteome identifies expected and novel proteins correlated with micronutrient status in undernourished Nepalese children. J. Nutr 2013, 143:1540-1548. doi: 1510.3945/jn.1113.175018. Epub 172013 Aug 175021.
11. Cupid B.C., Lightfoot T.J., Russell D., Gant S.J., Turner P.C., Dingley K.H., et al. The formation of AFB 1-macromolecular adducts in rats and humans at dietary levels of exposure. Food Chem. Toxicol 2004, 42:559-569.
12. Dawlatana M., Coker R.D., Nagler M.J., Wild C.P., Hassan M.S., Blunden G. The occurrence of mycotoxins in key commodities in Bangladesh: surveillance results from 1993 to 1995. J. Nat. Toxins 2002, 11:379-386.
13. Gong Y., Hounsa A., Egal S., Turner P.C., Sutcliffe A.E., Hall A.J., et al. Postweaning exposure to aflatoxin results in impaired child growth: a longitudinal study in Benin, West Africa. Environ. Health Perspect 2004, 112:1334-1338.
14. Gong Y.Y., Cardwell K., Hounsa A., Egal S., Turner P.C., Hall A.J., et al. Dietary aflatoxin exposure and impaired growth in young children from Benin and Togo: cross sectional study. BMJ 2002, 325:20-21.
15. Gong Y.Y., Egal S., Hounsa A., Turner P.C., Hall A.J., Cardwell K.F., et al. Determinants of aflatoxin exposure in young children from Benin and Togo, West Africa: the critical role of weaning. Int. J. Epidemiol 2003, 32:556-562.
16. Guengerich F.P. Cytochrome p450 and chemical toxicology. Chem. Res. Toxicol 2008, 21:70-83.
17. Katz J., Lee A.C., Kozuki N., Lawn J.E., Cousens S., Blencowe H., et al. Mortality risk in preterm and small-for-gestational-age infants in low-income and middle-income countries: a pooled country analysis. Lancet 2013, 382:417-425.
18. Kensler T.W., Roebuck B.D., Wogan G.N., Groopman J.D. Aflatoxin: a 50-year odyssey of mechanistic and translational toxicology. Toxicol. Sci 2011, 120(Suppl. 1):S28-S48.
19. Khlangwiset P., Shephard G.S., Wu F. Aflatoxins and growth impairment: a review. Crit. Rev. Toxicol 2011, 41:740-755.
20. Koirala P., Kumar S., Yadav B.K., Premarajan K.C. Occurrence of aflatoxin in some of the food and feed in Nepal. Indian J. Med. Sci 2005, 59:331-336.
21. Krishnamachari K.A., Bhat V.R., Nagarajan V., Tilak T.B., Tulpule P.G. The problem of aflatoxic human disease in parts of India-epidemiological and ecological aspects. Ann. Nutr. Aliment 1977, 31:991-996.
22. McCoy L.F., Scholl P.F., Schleicher R.L., Groopman J.D., Powers C.D., Pfeiffer C.M. Analysis of aflatoxin B1-lysine adduct in serum using isotope-dilution liquid chromatography/tandem mass spectrometry. Rapid Commun. Mass Spectrom 2005, 19:2203-2210.
23. McCoy L.F., Scholl P.F., Sutcliffe A.E., Kieszak S.M., Powers C.D., Rogers H.S., et al. Human aflatoxin albumin adducts quantitatively compared by ELISA, HPLC with fluorescence detection, and HPLC with isotope dilution mass spectrometry. Cancer Epidemiol. Biomarkers Prev 2008, 17:1653-1657.
24. Okumura H., Kawamura O., Kishimoto S., Hasegawa A., Shrestha S.M., Okuda K., et al. Aflatoxin M1 in Nepalese sera, quantified by combination of monoclonal antibody immunoaffinity chromatography and enzyme-linked immunosorbent assay. Carcinogenesis 1993, 14:1233-1235.
25. Sabbioni G., Ambs S., Wogan G.N., Groopman J.D. The aflatoxin B1-lysine adduct quantified by high-performance liquid chromatography from human serum albumin samples. Carcinogenesis 1990, 11:2063-2066.
26. Scholl P.F., Groopman J.D. Long-term stability of human aflatoxin B1 albumin adducts assessed by isotope dilution mass spectrometry and high-performance liquid chromatography-fluorescence. Cancer Epidemiol. Biomarkers Prev 2008, 17:1436-1439.
27. Scholl P.F., Turner P.C., Sutcliffe A.E., Sylla A., Diallo M.S., Friesen M.D., et al. Quantitative comparison of aflatoxin B1 serum albumin adducts in humans by isotope dilution mass spectrometry and ELISA. Cancer Epidemiol. Biomarkers Prev 2006, 15:823-826.
28. Scholl P.F., Cole R.N., Ruczinski I., Gucek M., Diez R., Rennie A., et al. Maternal serum proteome changes between the first and third trimester of pregnancy in rural southern Nepal. Placenta 2012, 33:424-432.
29. Smith L.E., Stoltzfus R.J., Prendergast A. Food chain mycotoxin exposure, gut health, and impaired growth: a conceptual framework. Adv. Nutr 2012, 3:526-531.
30. Strosnider H., Azziz-Baumgartner E., Banziger M., Bhat R.V., Breiman R., Brune M.N., et al. Workgroup report: public health strategies for reducing aflatoxin exposure in developing countries. Environ. Health Perspect 2006, 114:1898-1903.
31. Tandon H.D., Tandon B.N., Ramalingaswami V. Epidemic of toxic hepatitis in India of possible mycotoxic origin. Arch. Pathol. Lab. Med 1978, 102:372-376.
32. Turner P.C., Sylla A., Gong Y.Y., Diallo M.S., Sutcliffe A.E., Hall A.J., et al. Reduction in exposure to carcinogenic aflatoxins by postharvest intervention measures in West Africa: a community-based intervention study. Lancet 2005, 365:1950-1956.
33. Turner P.C., Collinson A.C., Cheung Y.B., Gong Y., Hall A.J., Prentice A.M., et al. Aflatoxin exposure in utero causes growth faltering in Gambian infants. Int. J. Epidemiol 2007, 36:1119-1125.
34. Wang L.Y., Hatch M., Chen C.J., Levin B., You S.L., Lu S.N., et al. Aflatoxin exposure and risk of hepatocellular carcinoma in Taiwan. Int. J. Cancer 1996, 67:620-625.
35. West K.P., Shamim A.A., Labrique A.B., Ali H., Shaikh S., Mehra S., et al. Efficacy of antenatal multiple micronutrient (MM) vs iron-folic acid (ifa) supplementation in improving gestational and postnatal viability in rural Bangladesh: the JiVitA-3 Trial. FASEB J. 2013, 27.
36. Wild C.P., Gong Y.Y. Mycotoxins and human disease: a largely ignored global health issue. Carcinogenesis 2010, 31:71-82.
37. Wild C.P., Hudson G.J., Sabbioni G., Chapot B., Hall A.J., Wogan G.N., et al. Dietary intake of aflatoxins and the level of albumin-bound aflatoxin in peripheral blood in The Gambia, West Africa. Cancer Epidemiol. Biomarkers Prev 1992, 1:229-234.
38. Wogan G.N., Kensler T.W., Groopman J.D. Present and future directions of translational research on aflatoxin and hepatocellular carcinoma: a review. Food Addit. Contam Part A Chem. Anal. Control Expo. Risk Assess 2012, 29:249-257.
39. Yadgiri B., Reddy V., Tulpule P.G., Srikantia S.G., Gopalan C. Aflatoxin and Indian childhood cirrhosis. Am. J. Clin. Nutr 1970, 23:94-98.